Matches in Wikidata for { <http://www.wikidata.org/entity/Q66063057> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q66063057 description "clinical trial" @default.
- Q66063057 description "ensayu clínicu" @default.
- Q66063057 description "klinisch onderzoek" @default.
- Q66063057 description "клінічне випробування" @default.
- Q66063057 name "A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer" @default.
- Q66063057 name "A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer" @default.
- Q66063057 type Item @default.
- Q66063057 label "A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer" @default.
- Q66063057 label "A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer" @default.
- Q66063057 prefLabel "A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer" @default.
- Q66063057 prefLabel "A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer" @default.
- Q66063057 P1132 Q66063057-260F9E8B-D59A-473F-9129-5C62756F95A9 @default.
- Q66063057 P1476 Q66063057-D54131CC-02A9-49D0-ABE9-1BFE6BBF8392 @default.
- Q66063057 P2899 Q66063057-021574DA-8EDA-4CD0-9B74-5155FA2E7BE8 @default.
- Q66063057 P3098 Q66063057-13C8C730-1D3E-42F7-8B49-4E2F8C0F2B6A @default.
- Q66063057 P31 Q66063057-395336A0-8031-4C4A-BA69-D186E629BD10 @default.
- Q66063057 P4135 Q66063057-4DDA5CBE-2DBB-4436-961A-349A57F06653 @default.
- Q66063057 P580 Q66063057-01B254D8-BFA4-449E-B360-29FD05308811 @default.
- Q66063057 P582 Q66063057-A75DEC13-C8E6-4914-8AD8-6E4F7D26B6D4 @default.
- Q66063057 P6099 Q66063057-685E4569-E273-459E-A4D5-6DE17B5B86C9 @default.
- Q66063057 P8363 Q66063057-064F57AC-6C24-48EE-836A-1211C4B70EE0 @default.
- Q66063057 P1132 "+256" @default.
- Q66063057 P1476 "A Randomized, Multicenter, Phase II Open-label Study of the Efficacy and Safety of Pyrotinib + Vinorelbine vs. Treatment of Physician's Choice in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trastuzumab-Based Therapy" @default.
- Q66063057 P2899 "+18" @default.
- Q66063057 P3098 "NCT03997539" @default.
- Q66063057 P31 Q30612 @default.
- Q66063057 P4135 "+70" @default.
- Q66063057 P580 "2019-08-15T00:00:00Z" @default.
- Q66063057 P582 "2021-06-30T00:00:00Z" @default.
- Q66063057 P6099 Q42824440 @default.
- Q66063057 P8363 Q78089383 @default.